Last Updated On 3/1/2024 6:19:56 PM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.
| Employment |
| Company: Massachusetts General Hospital Cancer Center |
| Recipient: You |
| Company: Massachusetts Medical Society |
| Recipient: You |
|
| Leadership |
| No Relationships to Disclose |
|
|
| Stock and Other Ownership Interests |
| Company: hC Bioscience |
| Recipient: You |
|
| Honoraria |
| Company: Medscape |
| Recipient: You |
|
| Consulting or Advisory Role |
| Company: GIMV NV |
| Recipient: You |
| Company: TigaTx Inc |
| Recipient: You |
| Company: hC Bioscience |
| Recipient: You |
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| Company: Ascendis Pharma A/S |
| Recipient: Your Institution |
| Company: Avenge Bio, Inc |
| Recipient: Your Institution |
| Company: Immunocore Limited |
| Recipient: Your Institution |
| Company: Duality Biologics |
| Recipient: Your Institution |
| Company: Merck Sharp & Dohme Corporation |
| Recipient: Your Institution |
| Company: ProfoundBio |
| Recipient: Your Institution |
|
| Patents, Royalties, Other Intellectual Property |
| Please describe: Dr. Yeku has a patent for MUC16 Directed Antibodies for therapeutic applications pending and a patent for Human Artificial Chromosomes for therapeutic applications pending. |
| Recipient: You |
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| Company: ASCO |
| Recipient: You |
|
| Other Relationship |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Uncompensated Relationships |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Open Payments Link |
| No Relationships to Disclose |
|
|